Previously we reported that PrPC level was unchanged in the brain in familial AD cases (with mutations in either APP or presenilin-1) [17], indicating that differentiating between the two forms of AD is crucial in evaluating any changes in PrPC. The gene discussed is APP; the disease is Alzheimer disease.